Cronos Group

Cronos Group Receivables

The Accounts Receivable of Cronos Group (CRON.TO) as of Oct 25, 2026 is 34.10 M USD. In the previous year, Accounts Receivable was 15.46 M USD — a change of 120.53% (higher).

Receivables

34.10 MUSD

YoY

120.53%

Last updated:

Accounts Receivable of Cronos Group is 2025 34.10 M USD. Accounts Receivable of Cronos Group was 2024 15.46 M USD. It decreases by 120.53% higher compared to the previous year.

The Cronos Group Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2018
3.10 M USD
Jan 1, 2019
4.60 M USD
Jan 1, 2020
8.90 M USD
Jan 1, 2021
22.07 M USD
Jan 1, 2022
23.11 M USD
Jan 1, 2023
13.98 M USD
Jan 1, 2024
15.46 M USD
Jan 1, 2025
34.10 M USD
The Cronos Group Receivables history
YEARReceivablesYoY
34.10 MUSD+120.53%
15.46 MUSD+10.57%
13.98 MUSD-39.50%
23.11 MUSD+4.74%
22.07 MUSD+147.94%
8.90 MUSD+93.48%
4.60 MUSD+48.39%
3.10 MUSD+244.44%
900,000.00USD+800.00%
100,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cronos Group Stock analysis

What does Cronos Group do? Cronos Group Inc is a Canadian company specializing in the production and distribution of medical and recreational cannabis. It was founded in 2013 and is headquartered in Toronto, Canada. Cronos Group Inc is one of the leading cannabis producers in Canada and has also made a name for itself in the international market. History Cronos Group Inc started as a medical cannabis startup focused on the cultivation and production of high-quality cannabis products for the medical market. In 2016, the company was listed on the Toronto Stock Exchange and raised 40 million Canadian dollars through a capital increase. In 2018, it received a $1.8 billion investment from Altria Group Inc, one of the world's largest tobacco companies. This investment helped Cronos grow and establish itself in the global cannabis market. Business model Cronos Group Inc has a diversified business model focusing on the production, processing, and marketing of cannabis products. The company specializes in the cultivation and production of high-quality cannabis products suitable for both the medical and recreational markets. Cronos Group Inc also produces cannabis oils, vaporizer pens, and other smoke-free products. The various subsidiaries Cronos Group Inc consists of several subsidiary companies focusing on different aspects of the cannabis industry. Some of the key subsidiaries of Cronos Group Inc are: 1. Peace Naturals - This company specializes in the cultivation of medical cannabis and also produces cannabis oils and vaporizable products. 2. Original BC - Original BC is a leading provider of recreational cannabis, offering a wide range of cannabis products. 3. Sublime Culture - Sublime Culture specializes in the production of cannabis extracts and the development of novel cannabis products like THC-infused gummy bears. Products Cronos Group Inc offers a wide range of cannabis products suitable for both the medical and recreational markets. Some of the key products of Cronos Group Inc include: 1. Cannabis oils - The company produces a wide range of cannabis oils suitable for medical and recreational use. 2. Vaporizer pens - Cronos Group Inc also produces vaporizable products for smoke-free consumption of cannabis products. 3. Edibles - The company also offers a range of novel cannabis products like THC-infused gummy bears, contributing to the growth of the market. Conclusion Cronos Group Inc is one of the leading cannabis companies worldwide specializing in the production and distribution of medical and recreational cannabis. The company has made a name for itself with its wide range of cannabis products and has grown and established itself in the international market through the investment from Altria Group Inc. Cronos Group Inc has implemented a diversified business model, offering medical cannabis, recreational cannabis, and novel cannabis products to grow in the increasing demand and provide its customers with a wide range of offerings. Cronos Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cronos Group stock

Accounts Receivable of Cronos Group is 34.10 M USD in 2025.

Accounts Receivable of Cronos Group changed from 15.46 M USD to 34.10 M USD, representing a 120.53% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Receivable Cronos Group since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's Cronos Group historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Cronos Group

All Key Metrics — Cronos Group